{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:23:11Z","timestamp":1789964591377,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1038\/emm.2017.281","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T03:01:08Z","timestamp":1519354868000},"page":"e449-e449","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Inhibition of TNF\u03b1-interacting protein \u03b1 (Tip\u03b1)-associated gastric carcinogenesis by BTG2\/TIS21 via downregulating cytoplasmic nucleolin expression"],"prefix":"10.1038","volume":"50","author":[{"given":"Preethi","family":"Devanand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Oya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhoshkumar","family":"Sundaramoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kye Yong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Auck","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Suganuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Kyoung","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,23]]},"reference":[{"key":"BFemm2017281_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359\u2013E386.","journal-title":"Int J Cancer"},{"key":"BFemm2017281_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5230\/jgc.2011.11.3.135","volume":"11","author":"A Shin","year":"2011","unstructured":"Shin A, Kim J, Park S . Gastric cancer epidemiology in Korea. J Gastric Cancer 2011; 11: 135\u2013140.","journal-title":"J Gastric Cancer"},{"key":"BFemm2017281_CR3","first-page":"295","volume":"58","author":"AB Hill","year":"1965","unstructured":"Hill AB . The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295\u2013300.","journal-title":"Proc R Soc Med"},{"key":"BFemm2017281_CR4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1128\/CMR.00011-10","volume":"23","author":"LE Wroblewski","year":"2010","unstructured":"Wroblewski LE, Peek RM Jr, Wilson KT . Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 2010; 23: 713\u2013739.","journal-title":"Clin Microbiol Rev"},{"key":"BFemm2017281_CR5","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1128\/IAI.61.5.1799-1809.1993","volume":"61","author":"MK Tummuru","year":"1993","unstructured":"Tummuru MK, Cover TL, Blaser MJ . Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 1993; 61: 1799\u20131809.","journal-title":"Infect Immun"},{"key":"BFemm2017281_CR6","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.1073\/pnas.90.12.5791","volume":"90","author":"A Covacci","year":"1993","unstructured":"Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791\u20135795.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2017281_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1146\/annurev.pathol.1.110304.100125","volume":"1","author":"JC Atherton","year":"2006","unstructured":"Atherton JC . The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu Rev Pathol 2006; 1: 63\u201396.","journal-title":"Annu Rev Pathol"},{"key":"BFemm2017281_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00432-004-0652-x","volume":"131","author":"M Suganuma","year":"2005","unstructured":"Suganuma M, Kurusu M, Suzuki K, Nishizono A, Murakami K, Fujioka T et al. New tumor necrosis factor-alpha-inducing protein released from Helicobacter pylori for gastric cancer progression. J Cancer Res Clin Oncol 2005; 131: 305\u2013313.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFemm2017281_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/ijc.23484","volume":"123","author":"M Suganuma","year":"2008","unstructured":"Suganuma M, Yamaguchi K, Ono Y, Matsumoto H, Hayashi T, Ogawa T et al. TNF-alpha-inducing protein, a carcinogenic factor secreted from H. pylori, enters gastric cancer cells. Int J Cancer 2008; 123: 117\u2013122.","journal-title":"Int J Cancer"},{"key":"BFemm2017281_CR10","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1002\/ijc.28582","volume":"134","author":"T Watanabe","year":"2014","unstructured":"Watanabe T, Takahashi A, Suzuki K, Kurusu-Kanno M, Yamaguchi K, Fujiki H et al. Epithelial-mesenchymal transition in human gastric cancer cell lines induced by TNF-alpha-inducing protein of Helicobacter pylori. Int J Cancer 2014; 134: 2373\u20132382.","journal-title":"Int J Cancer"},{"key":"BFemm2017281_CR11","doi-asserted-by":"crossref","first-page":"14511","DOI":"10.1016\/S0021-9258(18)98716-8","volume":"266","author":"BS Fletcher","year":"1991","unstructured":"Fletcher BS, Lim RW, Varnum BC, Kujubu DA, Koski RA, Herschman HR . Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters. J Biol Chem 1991; 266: 14511\u201314518.","journal-title":"J Biol Chem"},{"key":"BFemm2017281_CR12","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1073\/pnas.88.8.3353","volume":"88","author":"A Bradbury","year":"1991","unstructured":"Bradbury A, Possenti R, Shooter EM, Tirone F . Molecular cloning of PC3, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization. Proc Natl Acad Sci USA 1991; 88: 3353\u20133357.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2017281_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1054\/tice.2001.0220","volume":"34","author":"J Melamed","year":"2002","unstructured":"Melamed J, Kernizan S, Walden PD . Expression of B-cell translocation gene 2 protein in normal human tissues. Tissue Cell 2002; 34: 28\u201332.","journal-title":"Tissue Cell"},{"key":"BFemm2017281_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/BF01209594","volume":"121","author":"IK Lim","year":"1995","unstructured":"Lim IK, Lee MS, Lee SH, Kim NK, Jou I, Seo JS et al. Differential expression of TIS21 and TIS1 genes in the various organs of Balb\/c mice, thymic carcinoma tissues and human cancer cell lines. J Cancer Res Clin Oncol 1995; 121: 279\u2013284.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFemm2017281_CR15","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/carcin\/22.8.1271","volume":"22","author":"MA Ficazzola","year":"2001","unstructured":"Ficazzola MA, Fraiman M, Gitlin J, Woo K, Melamed J, Rubin MA et al. Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis. Carcinogenesis 2001; 22: 1271\u20131279.","journal-title":"Carcinogenesis"},{"key":"BFemm2017281_CR16","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1158\/0008-5472.CAN-03-1687","volume":"64","author":"K Struckmann","year":"2004","unstructured":"Struckmann K, Schraml P, Simon R, Elmenhorst K, Mirlacher M, Kononen J et al. Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma. Cancer Res 2004; 64: 1632\u20131638.","journal-title":"Cancer Res"},{"key":"BFemm2017281_CR17","doi-asserted-by":"publisher","first-page":"8310","DOI":"10.1038\/sj.onc.1208008","volume":"23","author":"H Kawakubo","year":"2004","unstructured":"Kawakubo H, Carey JL, Brachtel E, Gupta V, Green JE, Walden PD et al. Expression of the NF-kappaB-responsive gene BTG2 is aberrantly regulated in breast cancer. Oncogene 2004; 23: 8310\u20138319.","journal-title":"Oncogene"},{"key":"BFemm2017281_CR18","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1096\/fj.06-7548com","volume":"21","author":"S Farioli-Vecchioli","year":"2007","unstructured":"Farioli-Vecchioli S, Tanori M, Micheli L, Mancuso M, Leonardi L, Saran A et al. Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3. FASEB J 2007; 21: 2215\u20132225.","journal-title":"FASEB J"},{"key":"BFemm2017281_CR19","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1002\/hep.22212","volume":"47","author":"TJ Park","year":"2008","unstructured":"Park TJ, Kim JY, Oh SP, Kang SY, Kim BW, Wang HJ et al. TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop. Hepatology 2008; 47: 1533\u20131543.","journal-title":"Hepatology"},{"key":"BFemm2017281_CR20","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/cr.2009.72","volume":"19","author":"M Liu","year":"2009","unstructured":"Liu M, Wu H, Liu T, Li Y, Wang F, Wan H et al. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res 2009; 19: 828\u2013837.","journal-title":"Cell Res"},{"key":"BFemm2017281_CR21","doi-asserted-by":"publisher","first-page":"5581","DOI":"10.1111\/febs.13099","volume":"281","author":"P Devanand","year":"2014","unstructured":"Devanand P, Kim SI, Choi YW, Sheen SS, Yim H, Ryu MS et al. Inhibition of bladder cancer invasion by Sp1-mediated BTG2 expression via inhibition of DNA methyltransferase 1. FEBS J 2014; 281: 5581\u20135601.","journal-title":"FEBS J"},{"issue":"Suppl 1","key":"BFemm2017281_CR22","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/S0140-6736(15)60352-X","volume":"385","author":"AE Frampton","year":"2015","unstructured":"Frampton AE, Castellano L, Colombo T, Giovannetti E, Krell J, Jacob J et al. Integrated molecular analysis to investigate the role of microRNAs in pancreatic tumour growth and progression. Lancet 2015; 385 (Suppl 1): S37.","journal-title":"Lancet"},{"key":"BFemm2017281_CR23","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10585-012-9479-z","volume":"29","author":"SK Lim","year":"2012","unstructured":"Lim SK, Choi YW, Lim IK, Park TJ . BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria. Clin Exp Metastasis 2012; 29: 901\u2013913.","journal-title":"Clin Exp Metastasis"},{"key":"BFemm2017281_CR24","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s00432-013-1484-3","volume":"139","author":"JA Choi","year":"2013","unstructured":"Choi JA, Lim IK . TIS21\/BTG2 inhibits invadopodia formation by downregulating reactive oxygen species level in MDA-MB-231 cells. J Cancer Res Clin Oncol 2013; 139: 1657\u20131665.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFemm2017281_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/onc.2015.64","volume":"35","author":"JA Choi","year":"2016","unstructured":"Choi JA, Jung YS, Kim JY, Kim HM, Lim IK . Inhibition of breast cancer invasion by TIS21\/BTG2\/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes. Oncogene 2016; 35: 83\u201393.","journal-title":"Oncogene"},{"key":"BFemm2017281_CR26","doi-asserted-by":"publisher","first-page":"8257","DOI":"10.1038\/ncomms9257","volume":"6","author":"K Tajima","year":"2015","unstructured":"Tajima K, Yae T, Javaid S, Tam O, Comaills V, Morris R et al. SETD1A modulates cell cycle progression through a miRNA network that regulates p53 target genes. Nat Commun 2015; 6: 8257.","journal-title":"Nat Commun"},{"key":"BFemm2017281_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0014-5793(01)02436-X","volume":"497","author":"S Matsuda","year":"2001","unstructured":"Matsuda S, Rouault J, Magaud J, Berthet C . In search of a function for the TIS21\/PC3\/BTG1\/TOB family. FEBS Lett 2001; 497: 67\u201372.","journal-title":"FEBS Lett"},{"key":"BFemm2017281_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/(SICI)1098-2744(199809)23:1<25::AID-MC4>3.0.CO;2-G","volume":"23","author":"IK Lim","year":"1998","unstructured":"Lim IK, Lee MS, Ryu MS, Park TJ, Fujiki H, Eguchi H et al. Induction of growth inhibition of 293 cells by downregulation of the cyclin E and cyclin-dependent kinase 4 proteins due to overexpression of TIS21. Mol Carcinog 1998; 23: 25\u201335.","journal-title":"Mol Carcinog"},{"key":"BFemm2017281_CR29","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1128\/MCB.20.5.1797-1815.2000","volume":"20","author":"D Guardavaccaro","year":"2000","unstructured":"Guardavaccaro D, Corrente G, Covone F, Micheli L, D'Agnano I, Starace G et al. Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription. Mol Cell Biol 2000; 20: 1797\u20131815.","journal-title":"Mol Cell Biol"},{"key":"BFemm2017281_CR30","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1007\/s11033-009-9777-y","volume":"37","author":"L Zhang","year":"2010","unstructured":"Zhang L, Huang H, Wu K, Wang M, Wu B . Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro. Mol Biol Rep 2010; 37: 2579\u20132586.","journal-title":"Mol Biol Rep"},{"key":"BFemm2017281_CR31","doi-asserted-by":"crossref","first-page":"51943","DOI":"10.18632\/oncotarget.10460","volume":"7","author":"L Zhou","year":"2016","unstructured":"Zhou L, Liang X, Zhang L, Yang L, Nagao N, Wu H et al. MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2. Oncotarget 2016; 7: 51943\u201351954.","journal-title":"Oncotarget"},{"key":"BFemm2017281_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.yexcr.2004.05.014","volume":"299","author":"MS Ryu","year":"2004","unstructured":"Ryu MS, Lee MS, Hong JW, Hahn TR, Moon E, Lim IK . TIS21\/BTG2\/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression. Exp Cell Res 2004; 299: 159\u2013170.","journal-title":"Exp Cell Res"},{"key":"BFemm2017281_CR33","doi-asserted-by":"publisher","first-page":"21256","DOI":"10.1074\/jbc.M500318200","volume":"280","author":"JW Hong","year":"2005","unstructured":"Hong JW, Ryu MS, Lim IK . Phosphorylation of serine 147 of tis21\/BTG2\/pc3 by p-Erk1\/2 induces Pin-1 binding in cytoplasm and cell death. J Biol Chem 2005; 280: 21256\u201321263.","journal-title":"J Biol Chem"},{"key":"BFemm2017281_CR34","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.cellsig.2016.05.014","volume":"28","author":"OR Choi","year":"2016","unstructured":"Choi OR, Ryu MS, Lim IK . Shifting p53-induced senescence to cell death by TIS21(\/BTG2\/Pc3) gene through posttranslational modification of p53 protein. Cell Signal 2016; 28: 1172\u20131185.","journal-title":"Cell Signal"},{"key":"BFemm2017281_CR35","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1634\/stemcells.2008-0327","volume":"26","author":"BC Kim","year":"2008","unstructured":"Kim BC, Ryu MS, Oh SP, Lim IK . TIS21\/(BTG2) negatively regulates estradiol-stimulated expansion of hematopoietic stem cells by derepressing Akt phosphorylation and inhibiting mTOR signal transduction. Stem Cells 2008; 26: 2339\u20132348.","journal-title":"Stem Cells"},{"key":"BFemm2017281_CR36","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1002\/eji.200526345","volume":"35","author":"MA Konrad","year":"2005","unstructured":"Konrad MA, Zuniga-Pflucker JC . The BTG\/TOB family protein TIS21 regulates stage-specific proliferation of developing thymocytes. Eur J Immunol 2005; 35: 3030\u20133042.","journal-title":"Eur J Immunol"},{"key":"BFemm2017281_CR37","doi-asserted-by":"publisher","first-page":"33110","DOI":"10.1074\/jbc.M804255200","volume":"283","author":"YB Lim","year":"2008","unstructured":"Lim YB, Park TJ, Lim IK . B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage. J Biol Chem 2008; 283: 33110\u201333118.","journal-title":"J Biol Chem"},{"key":"BFemm2017281_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/1-4020-5466-1_7","volume":"41","author":"S Storck","year":"2007","unstructured":"Storck S, Shukla M, Dimitrov S, Bouvet P . Functions of the histone chaperone nucleolin in diseases. Subcell Biochem 2007; 41: 125\u2013144.","journal-title":"Subcell Biochem"},{"issue":"Pt 6","key":"BFemm2017281_CR39","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1242\/jcs.112.6.761","volume":"112","author":"H Ginisty","year":"1999","unstructured":"Ginisty H, Sicard H, Roger B, Bouvet P . Structure and functions of nucleolin. J Cell Sci 1999; 112 (Pt 6): 761\u2013772.","journal-title":"J Cell Sci"},{"key":"BFemm2017281_CR40","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00432-009-0733-y","volume":"136","author":"T Watanabe","year":"2010","unstructured":"Watanabe T, Tsuge H, Imagawa T, Kise D, Hirano K, Beppu M et al. Nucleolin as cell surface receptor for tumor necrosis factor-alpha inducing protein: a carcinogenic factor of Helicobacter pylori. J Cancer Res Clin Oncol 2010; 136: 911\u2013921.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFemm2017281_CR41","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/apm.12131","volume":"121","author":"W Qiu","year":"2013","unstructured":"Qiu W, Zhou F, Zhang Q, Sun X, Shi X, Liang Y et al. Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer. APMIS 2013; 121: 919\u2013925.","journal-title":"APMIS"},{"key":"BFemm2017281_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1478-811X-11-69","volume":"11","author":"S Sundaramoorthy","year":"2013","unstructured":"Sundaramoorthy S, Ryu MS, Lim IK . B-cell translocation gene 2 mediates crosstalk between PI3K\/Akt1 and NFkappaB pathways which enhances transcription of MnSOD by accelerating IkappaBalpha degradation in normal and cancer cells. Cell Commun Signal 2013; 11: 69.","journal-title":"Cell Commun Signal"},{"key":"BFemm2017281_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0002-9270(00)02240-1","volume":"96","author":"HH Xia","year":"2001","unstructured":"Xia HH, Talley NJ . Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol 2001; 96: 16\u201326.","journal-title":"Am J Gastroenterol"},{"key":"BFemm2017281_CR44","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/gut.42.2.227","volume":"42","author":"IL Beales","year":"1998","unstructured":"Beales IL, Calam J . Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 1998; 42: 227\u2013234.","journal-title":"Gut"},{"key":"BFemm2017281_CR45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000103890","volume":"25","author":"G Nardone","year":"2007","unstructured":"Nardone G, Compare D, De Colibus P, de Nucci G, Rocco A . Helicobacter pylori and epigenetic mechanisms underlying gastric carcinogenesis. Dig Dis 2007; 25: 225\u2013229.","journal-title":"Dig Dis"},{"key":"BFemm2017281_CR46","doi-asserted-by":"publisher","first-page":"39284","DOI":"10.1074\/jbc.M505275200","volume":"280","author":"K Hirano","year":"2005","unstructured":"Hirano K, Miki Y, Hirai Y, Sato R, Itoh T, Hayashi A et al. A multifunctional shuttling protein nucleolin is a macrophage receptor for apoptotic cells. J Biol Chem 2005; 280: 39284\u201339293.","journal-title":"J Biol Chem"},{"key":"BFemm2017281_CR47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2012.03.027","volume":"322","author":"M Suganuma","year":"2012","unstructured":"Suganuma M, Watanabe T, Yamaguchi K, Takahashi A, Fujiki H . Human gastric cancer development with TNF-alpha-inducing protein secreted from Helicobacter pylori. Cancer Lett 2012; 322: 133\u2013138.","journal-title":"Cancer Lett"},{"key":"BFemm2017281_CR48","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1124\/mol.109.055947","volume":"76","author":"S Soundararajan","year":"2009","unstructured":"Soundararajan S, Wang L, Sridharan V, Chen W, Courtenay-Luck N, Jones D et al. Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells. Mol Pharmacol 2009; 76: 984\u2013991.","journal-title":"Mol Pharmacol"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/emm2017281.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/emm2017281","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/emm.2017.281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/emm2017281.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:21:39Z","timestamp":1684416099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/emm2017281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["BFemm2017281"],"URL":"https:\/\/doi.org\/10.1038\/emm.2017.281","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"28 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}